Stay updated on A4250 in Children With PFIC Types 1 or 2 Clinical Trial.
Sign up to get notified when there's something new on the A4250 in Children With PFIC Types 1 or 2 Clinical Trial. page.

Latest updates to the A4250 in Children With PFIC Types 1 or 2 Clinical Trial. page
- Check4 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2, with removal of the Back to Top link. No substantive changes to core content, pricing, stock, or time-slot information.SummaryDifference0.2%
- Check11 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.2%
- Check18 days agoChange DetectedThe webpage has been updated to include new drug information for Odevixibat and additional related topics, while also removing some previous location details and references to genetic disease resources.SummaryDifference4%
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check39 days agoChange DetectedThe web page has been updated from version v2.16.10 to v2.16.11.SummaryDifference0.1%
- Check47 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference1%
Stay in the know with updates to A4250 in Children With PFIC Types 1 or 2 Clinical Trial.
Enter your email address, and we'll notify you when there's something new on the A4250 in Children With PFIC Types 1 or 2 Clinical Trial. page.